Dermatology focuses on the health of the skin, hair, and nails. Learn about the diagnosis and treatment of acne, eczema, skin cancer, and cosmetic procedures.
Send us all your questions or requests, and our expert team will assist you.
Effective diagnosis and evaluation are the cornerstones of successful urticaria management, especially for international patients seeking specialized care. At Liv Hospital, our multidisciplinary team combines clinical expertise with state‑of‑the‑art diagnostics to identify the underlying triggers and formulate personalized treatment plans. Recent studies indicate that up to 25% of adults experience chronic urticaria at some point, highlighting the importance of timely and accurate assessment. This page walks you through the step‑by‑step process of evaluating urticaria, from initial history taking to advanced laboratory testing, ensuring you understand every facet of your care journey.
Whether you are dealing with an acute flare or persistent hives, our comprehensive approach aims to uncover hidden causes, differentiate similar skin conditions, and set the stage for long‑term relief. Read on to discover how our systematic evaluation process can help you regain control of your skin health.
Urticaria, commonly known as hives, presents as raised, itchy welts that can appear suddenly and vary in size. Recognizing the pattern of lesions and their relationship to potential triggers is the first step in a thorough diagnosis. While many cases are idiopathic, several factors frequently contribute to outbreaks:
During the initial consultation, clinicians document the timing, duration, and distribution of wheals, as well as any associated angioedema. This detailed history guides subsequent testing and helps differentiate acute urticaria (lasting < 6 weeks) from chronic forms (persisting > 6 weeks).
By systematically cataloguing these elements, the team at Liv Hospital creates a solid foundation for the subsequent phases of evaluation.
Beyond the visual inspection of wheals, a comprehensive symptom assessment captures the full impact of urticaria on a patient’s quality of life. Clinicians use validated tools such as the Urticaria Activity Score (UAS7) and the Dermatology Life Quality Index (DLQI) to quantify severity and functional impairment.
These data points are recorded in a structured electronic health record, enabling trend analysis over time. For international patients, the assessment forms are available in multiple languages, and interpreter services are provided to ensure accurate symptom reporting.
When the clinical picture alone does not reveal a clear cause, targeted laboratory investigations become essential. At Liv Hospital, the diagnostic work‑up is tailored to each patient’s history and presentation, balancing thoroughness with cost‑effectiveness.
All samples are processed in our JCI‑accredited laboratory, guaranteeing rapid turnaround and high analytical standards. Results are reviewed by board‑certified dermatologists and immunologists, who integrate findings into a cohesive evaluation strategy.
Accurate diagnosis and evaluation require ruling out conditions that mimic urticaria. Misdiagnosis can lead to ineffective treatment and prolonged discomfort. The following table outlines key differentiators:
By systematically comparing clinical signs, laboratory results, and patient history, the Liv Hospital team narrows the differential and confirms true urticaria, paving the way for targeted therapy.
Once the underlying cause—or lack thereof—is identified, a personalized treatment plan is crafted. The plan aligns with international guidelines (e.g., EAACI/GA²LEN/EDF/WAO) while incorporating patient preferences, comorbidities, and lifestyle considerations.
All medication regimens are reviewed by our pharmacists to avoid drug interactions, especially important for patients traveling from abroad who may be on concurrent therapies. Education sessions, provided in the patient’s native language, ensure adherence and empower patients to recognize early signs of relapse.
Urticaria often requires ongoing surveillance to assess treatment efficacy and adjust therapy. Liv Hospital schedules regular follow‑up visits, during which clinicians reassess symptom scores, repeat pertinent labs, and evaluate quality‑of‑life outcomes.
For international patients, tele‑medicine consultations are available, allowing seamless continuity of care after returning home. The multidisciplinary team remains accessible for urgent concerns, ensuring that flare‑ups are managed promptly and safely.
Liv Hospital combines JCI‑accredited excellence with a dedicated international patient program. Our dermatology specialists bring years of experience in complex urticaria cases, supported by cutting‑edge diagnostics and personalized care pathways. From visa assistance to airport transfers and multilingual interpreter services, we handle every logistical detail so you can focus on healing. Trust Liv Hospital for a seamless, world‑class experience in the diagnosis and evaluation of urticaria.
Ready to take control of your skin health? Contact our international patient desk today to schedule a comprehensive evaluation and start your personalized treatment plan at Liv Hospital.
Liv Hospital Ulus
Asst. Prof. MD. Ayşe Deniz Akkaya
Dermatology
Liv Hospital Ulus
Asst. Prof. MD. Nazlı Caf
Dermatology
Liv Hospital Ulus
Prof. MD. İlteriş Oğuz
Dermatology
Liv Hospital Ulus
Spec. MD. Ömer Gezdur
Dermatology
Liv Hospital Vadistanbul
Assoc. Prof. MD. Ece Altun
Dermatology
Liv Hospital Vadistanbul
Prof. MD. Sevilay Oğuz Kılıç
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Marziyeh Javadpour
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Meryem Ayşit
Dermatology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Nadir Göksügür
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Esengül Kaya
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Vedat Ertunç
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Özlem İpek
Dermatology
Liv Hospital Topkapı
Spec. MD. Betül Kızılkan
Dermatology
Liv Hospital Topkapı
Spec. MD. Gizem Gökçedağ Ünsal
Dermatology
Liv Hospital Ankara
Asst. Prof. MD. Caner Demircan
Dermatology
Liv Hospital Ankara
Spec. MD. Aylin Gözübüyükoğulları
Dermatology
Liv Hospital Ankara
Spec. MD. Elçin Akdaş
Dermatology
Liv Hospital Ankara
Spec. MD. Vahid Ahmadi
Dermatology
Liv Hospital Gaziantep
Spec. MD. Hatice Kübra Çakı
Dermatology
Liv Hospital Samsun
Asst. Prof. MD. Gül Şekerlisoy Tatar
Dermatology
Liv Hospital Samsun
Spec. MD. Ayşe İdil Baş
Dermatology
Liv Bona Dea Hospital Bakü
Spec. MD. İRFAN QEHREMANOV
Dermatology
Asst. Prof. MD. A. Deniz Akkaya
Dermatology
MD. Gül Şekerlisoy Tatar
Dermatology
Send us all your questions or requests, and our expert team will assist you.
Urticaria can be provoked by a variety of factors. Food allergens such as nuts, shellfish, and dairy often cause rapid onset hives. Medications like antibiotics, NSAIDs, and ACE inhibitors may trigger reactions within 24–48 hours. Infections—viral, bacterial, or parasitic—can also lead to hives. Physical stimuli (cold, heat, pressure, sunlight) produce localized wheals. Autoimmune conditions, especially thyroid disease, are linked to chronic urticaria. Additionally, stress and hormonal fluctuations can exacerbate symptoms. Identifying the specific trigger through detailed history and targeted testing is essential for effective management.
At Liv Hospital, clinicians evaluate urticaria severity with standardized instruments. The Urticaria Activity Score over 7 days (UAS7) records the number of wheals and itch intensity daily, providing a quantitative measure of disease activity. The Dermatology Life Quality Index (DLQI) assesses the impact on daily functioning, work, and emotional well‑being. Together, these scores guide treatment decisions, monitor response, and help tailor therapy to each patient’s needs, especially for international patients who may have language barriers.
When routine evaluation does not reveal a cause, Liv Hospital orders a targeted panel. A complete blood count checks for eosinophilia, while serum IgE levels can indicate allergic involvement. Thyroid function tests (TSH, free T4) screen for autoimmune thyroid disease, a known association with chronic urticaria. An antinuclear antibody (ANA) test evaluates systemic autoimmunity, and complement C3/C4 levels help identify hereditary angioedema. If suspicion remains, skin prick or intradermal testing, patch testing, autologous serum skin test (ASST), or basophil activation test may be performed to pinpoint specific allergens or autoimmune mechanisms.
Urticaria is distinguished from mimicking disorders by several key factors. Vasculitis presents with painful purpura lasting more than 24 hours and requires a skin biopsy showing vessel wall inflammation. Erythema multiforme features target lesions, often on palms and soles, linked to infections or drugs. Contact dermatitis is localized to the area of exposure and may be vesicular, confirmed by a positive patch test. Hereditary angioedema causes deep, non‑urticarial swelling with low C1‑esterase inhibitor levels. By systematically comparing these signs with patient history and lab data, Liv Hospital accurately identifies true urticaria.
BlogDermatologyMar 19, 2026Understand the causes and progression of cold urticaria, a condition that leads to distressing cold rashes....
BlogDermatologyDec 23, 2025Urticaria is a condition that makes your skin itchy and swell. It affects millions of people worldwide. Nea...
BlogDermatologyMar 19, 2026Dealing with warts can be frustrating and painful. Many people think about removing them at home. But tryin...
BlogDermatologyMar 19, 2026Toothpaste is often seen as a quick solution for warts. But is it really effective or just a myth? We look ...
BlogDermatologyDec 29, 2025Up to 20% of people get hives at some point, and kids are more likely to get them. Seeing your child with h...
BlogDermatologyMar 19, 2026Discover the causes, symptoms, and effective treatments for hives - a common allergic skin condition affect...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 28 17